MISC - HASE Tetsunari
-
Nakamura, S; Hase, T; Takada, Y; Iwashimizu, H; Imamura, Y; Okado, S; Nomata, Y; Watanabe, H; Noritake, O; Nakanishi, K; Kadomatsu, Y; Ueno, H; Kato, T; Mizuno, T; Ishii, M; Chen-Yoshikawa, TF
JOURNAL OF THORACIC ONCOLOGY Vol. 18 ( 11 ) page： S489 - S490 2023.11
-
CEBP gamma and YBX1 regulate lung cancer metastasis via CERS6 expression and lamellipodia formation.
Shi Hanxiao, Niimi Atsuko, Takeuchi Toshiyuki, Mizutani Yasuyoshi, Shiogama Kazuya, Inada Kenichi, Hase Tetsunari, Hasegawa Yoshinori, Takahashi Takashi, Suzuki Motoshi
CANCER SCIENCE Vol. 112 page： 700 - 700 2021.2
-
Pharmacokinetic and dose finding study of osimertinib in patients with impaired renal function and low body weight
Hase T., Fujiwara Y., Makihara R. A., Hashimoto N., Tsubata Y., Okuno T., Naito T., Takahashi T., Kobayashi H., Shinno Y., Ikeda T., Goto K., Hosomi Y., Watanabe K., Kitazono S., Sakiyama N., Makino Y., Yamamoto N.
ANNALS OF ONCOLOGY Vol. 32 page： S982 - S983 2021
-
PREDICT1: An observational study for identifying blood biomarkers associated with clinical benefit from carboplatin and pemetrexed (CbP) treatment in patients with non-squamous (NS) non-small cell lung cancer (NSCLC) (CJLSG1201).
Hase Tetsunari, Yanagisawa Kiyoshi, Fukatsu Asuki, Kimura Tomoki, Kojima Eiji, Abe Takashi, Imaizumi Kazuyoshi, Horio Yoshitsugu, Oguri Tetsuya, Yamamoto Masashi, Ogasawara Tomohiko, Sugino Yasuteru, Morise Masahiro, Nakatochi Masahiro, Ando Masahiko, Kondo Masashi, Saka Hideo, Saito Hiroshi, Hasegawa Yoshinori, Takahashi Takashi
JOURNAL OF CLINICAL ONCOLOGY Vol. 38 ( 15 ) 2020.5
-
Prognostic Factors in Myositis-Related Interstitial Lung Disease: A Retrospective Multicenter Study
Waseda Y., Shiraki A., Saeki K., Watanabe S., Shoda T., Ishida T., Makino S., Tomii K., Hase T., Hasegawa Y., Okamoto M., Izumi S., Miyamoto A., Kishi K., Kishaba T., Nara M., Komatsuda A., Arita M., Kawamura K., Ichikado K., Koreeda Y., Mitsuma T., Hamaguchi Y., Muro Y., Egashira R., Sumikawa H., Ishizuka T., Johkoh T.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE Vol. 201 2020
-
Exosomal Analysis of ALK Rearrangements by Spin Column with Porous Glass Filter
Hatta T., Hase T., Ozawa N., Yogo N., Yukawa H., Tanaka H., Onoshima D., Sato M., Hori M., Baba Y., Hasegawa Y.
JOURNAL OF THORACIC ONCOLOGY Vol. 14 ( 10 ) page： S676 - S676 2019.10
-
UHRF1 as a Potential Therapeutic Target for KRAS Mutated Non-Small Cell Lung Cancer
Goto D., Kizuki M., Uwatoko N., Kawai K., Koike M., Nakashima M., Miyazawa A., Tanaka I., Hase T., Morise M., Hasegawa Y., Minna J., Sato M.
JOURNAL OF THORACIC ONCOLOGY Vol. 14 ( 10 ) page： S692 - S692 2019.10
-
Serum CRP Decrease Has Predictive Value for LongTerm Disease Control by PD-1/ PD-L1 Inhibitors in Patients with NSCLC
Matsuzawa R., Morise M., Tanaka I., Koyama J., Kimura T., Kondoh Y., Hase T., Sakamoto K., Hashimoto N., Hasegawa Y.
JOURNAL OF THORACIC ONCOLOGY Vol. 14 ( 10 ) page： S716 - S716 2019.10
-
Impact of Combined Evaluation Using Tumor Volume and Metastatic Nodal Extent in Stage III NSCLC Treated with CRT
Tamiya Y., Morise M., Matsuzawa R., Tanaka I., Okada T., Iwano S., Hase T., Hashimoto N., Sato M., Itoh Y., Hasegawa Y.
JOURNAL OF THORACIC ONCOLOGY Vol. 14 ( 10 ) page： S909 - S910 2019.10
-
Analysis of Clinical Features by Both Diagnosis and Types of Antibodies in Patients with Myositis Related Interstitial Lung Disease: A Retrospective Multicenter Study
Waseda Y., Shiraki A., Saeki K., Watanabe S., Shoda T., Ishida T., Makino S., Tomii K., Hase T., Hasegawa Y., Okamoto M., Izumi S., Miyamoto A., Kishi K., Kishaba T., Nara M., Komatsuda A., Arita M., Kawamura K., Ichikado K., Koreeda Y., Mitsuma T., Hamaguchi Y., Muro Y., Egashira R., Sumikawa H., Ishizuka T., Johkoh T.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE Vol. 199 2019
-
Development of the immuno-wall device for rapid detection of ALK and ROS1 fusions in lung cancer
Yogo N., Hase T., Kasama T., Hatta T., Ozawa N., Sato M., Kaji N., Tokeshi M., Baba Y., Hasegawa Y.
ANNALS OF ONCOLOGY Vol. 29 2018.11
-
Retrospective analysis of risk factor of injection site reaction induced by infusion of cisplatin plus vinorelbine
Ozawa N., Hase T., Hatta T., Sagara A., Ichikawa K., Miyazaki M., Ando M., Yamada K., Hasegawa Y.
ANNALS OF ONCOLOGY Vol. 29 2018.11
-
eIF2 beta, A Subunit of Translation-Initiation Factor EIF2, as a Potential Therapeutic Target for Non-Small Cell Lung Cancer
Goto D., Tanaka I., Sato M., Kato T., Miyazawa A., Hase T., Morise M., Sekido Y., Girard L., Minna J., Byers L., Heymach J., Coombes K., Kondo M., Hasegawa Y.
JOURNAL OF THORACIC ONCOLOGY Vol. 13 ( 10 ) page： S516 - S517 2018.10
-
Short Hydration Regimen with a Modified Dose of Magnesium Supplementation for Lung Cancer Patients Receiving Cisplatin-Based Chemotherapy
Hase T., Miyazaki M., Ichikawa K., Yogo N., Ozawa N., Ando M., Morise M., Sato M., Kondo M., Yamada K., Hasegawa Y.
JOURNAL OF THORACIC ONCOLOGY Vol. 13 ( 10 ) page： S880 - S880 2018.10
-
Development of the immuno-wall device for rapid, low-cost detection of EGFR mutations in tumor samples from patients with lung cancer
Yogo N., Hase T., Kasama T., Ozawa N., Sato M., Kaji N., Tokeshi M., Baba Y., Hasegawa Y.
ANNALS OF ONCOLOGY Vol. 28 2017.11
-
Phase I study of combined therapy with vorinostat and gefitinib to treat BIM deletion polymorphism-associated resistance in EGFR-mutant lung cancer (VICTROY-J)
Hase T., Takeuchi S., Ando M., Hata A., Kenmotsu H., Fujiwara T., Shimizu S., Nagase K., Yoshimura K., Katakami N., Takahashi T., Hasegawa Y., Yano S.
ANNALS OF ONCOLOGY Vol. 28 2017.11
-
Identification of Proteosomal Catalytic Subunit PSMA6 as a Therapeutic Target for Lung Cancer through a Pooled shRNA Screen
Sato M., Kakumu T., Goto D., Kato T., Yogo N., Hase T., Morise M., Fukui T., Yokoi K., Sekido Y., Girard L., Minna J., Byers L., Heymach J., Coombes K., Kondo M., Hasegawa Y.
JOURNAL OF THORACIC ONCOLOGY Vol. 12 ( 11 ) page： S2277 - S2278 2017.11